Contraceptive and noncontraceptive benefits of the LNG-IUS in a vertically integrated HMO.
Contraception
; 78(1): 36-41, 2008 Jul.
Article
en En
| MEDLINE
| ID: mdl-18555816
ABSTRACT
BACKGROUND:
The study was conducted to assess outcomes among women using the levonorgestrel-releasing intrauterine system (LNG-IUS). STUDYDESIGN:
The data were collected via a retrospective claims database analysis of 152 women. Two nested cohorts were further distinguished based on length of follow-up two and three continuous years (n=73 and n=29, respectively).RESULTS:
Over 90% had a single insertion, and fewer than 4% experienced an LNG-IUS-related complication. Thirteen percent of women experienced menorrhagia in the year preceding insertion; this figure dropped to 12.5%, 1.2% and 0% in the 1, 2 and 3 years postinsertion. Mean number of gynecology-related visits decreased from four to two in the overall cohort, from seven to four in the cohort with 2 years of follow-up and from nine to four in the cohort with 3 years of follow-up.CONCLUSION:
LNG-IUS use prevented pregnancy in all patients and was associated with decreased vaginal bleeding starting in the second year postinsertion.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Levonorgestrel
/
Servicios de Planificación Familiar
/
Dispositivos Intrauterinos Medicados
/
Menorragia
Tipo de estudio:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Contraception
Año:
2008
Tipo del documento:
Article
País de afiliación:
Estados Unidos